Our Mission: Curing rare disease in a single dose.
Just as enzyme replacement therapies (ERTs) revolutionized the past, gene therapy has the potential to revolutionize the future.
Recent News
February 6, 2019
AVROBIO, Inc. Announces Updated Clinical Data from Ongoing Phase 1 and Phase 2 Studies for AVR-RD-01 Gene Therapy for Fabry Disease
February 1, 2019
AVROBIO, Inc. Announces Time Change for Analyst and Investor Presentation and Webcast, now 5:30 p.m. ET on Wednesday, February 6, 2019